In our study, higher counts of TILs are significantly (p < 0.001) associated with more aggressive tumor features such as loss of estrogen receptor, higher tumor grade (G3), or her2/neu over-expression in ductal breast cancers. Here, ERBB2 is linked to breast cancer.